← Leaderboards
Yan Dong
Tulane University Of Louisiana
$1,877,893
Attributed
$2,194,346
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $632.9K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,194,346 · 2
VA$0 · 1
By mechanism
R01$2,194,346 · 2
I01$0 · 1
Top collaborators
- Erik K Flemington1 shared
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Mansour Mohamadzadeh$10,672,310
Others in their field
Top investigators on “Resistance”
- Judith S. Currier · University Of California Los Angeles$243,611,225
- Gregory H Reaman · National Childhood Cancer Foundation$217,720,574
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$180,092,958
- Ralph Parchment · Leidos Biomedical Research, Inc.$149,556,948
- Wafaa M. El-Sadr · Columbia University Health Sciences$113,991,858
- Peter C Adamson · National Childhood Cancer Foundation$113,790,601
Research focus
ResistanceMediatingMalignant Neoplasm Of ProstateAutomobile DrivingDisease ProgressionProstate Cancer TherapyCastrationEffective TherapyNovel TherapeuticsData SetClinically RelevantSamplingBiological ModelsProstateProstate Cancer ProgressionMetastatic Prostate CancerBaseCell LineAttenuatedAssay DevelopmentAerobic GlycolysisBiologyAreaDiminished Oxidative Phosphorylation
Grant awards (12)
RNA-binding as a new paradigm for androgen receptor-mediated prostate cancer therapeutic resistance$632,906
R01 · FY2025 · CA · contact PI
A role of FAM3B in suppressing prostate cancer progression$0
I01 · FY2025 · VA · contact PI
A role of FAM3B in suppressing prostate cancer progression$0
I01 · FY2024 · VA · contact PI
A role of FAM3B in suppressing prostate cancer progression$0
I01 · FY2023 · VA · contact PI
A role of FAM3B in suppressing prostate cancer progression$0
I01 · FY2022 · VA · contact PI
A role of FAM3B in suppressing prostate cancer progression$0
I01 · FY2021 · VA · contact PI
A role of FAM3B in suppressing prostate cancer progression$0
I01 · FY2020 · VA · contact PI
An inevitable mechanism of resistance to androgen-directed therapy$312,288
R01 · FY2018 · CA · contact PI
An inevitable mechanism of resistance to androgen-directed therapy$312,288
R01 · FY2017 · CA · contact PI
An inevitable mechanism of resistance to androgen-directed therapy$312,288
R01 · FY2016 · CA · contact PI
An inevitable mechanism of resistance to androgen-directed therapy$312,288
R01 · FY2015 · CA · contact PI
An inevitable mechanism of resistance to androgen-directed therapy$312,288
R01 · FY2014 · CA · contact PI